IL10 and ovarian carcinoma: Our natural epigenetic treatments downregulated the secretion of IL-10, associated with induction of proliferation, migration, and immunosuppression in ovarian cancer [58,59], by more than 70%, an effect comparable to that obtained by treatment with the synthetic compound Pano.